GAM
SGMO

Gotham Asset Management’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

Gotham Asset Management’s Portfolio SGMO Stock Details SGMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-26,695
Closed -$400K – 1048
2017
Q3 		$400K Buy
+26,695
New +$295K 0.01% 743
2015
Q3 		– Sell
-30,334
Closed -$336K – 1027
2015
Q2 		$336K Buy
+30,334
New +$391K ﹤0.01% 800
2015
Q1 		– Sell
-17,441
Closed -$265K – 1014
2014
Q4 		$265K Buy
+17,441
New +$212K ﹤0.01% 857

Other funds holding SGMO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CCS
Crosspoint Capital Strategies Orinda, California $50.4M AUM 15.37% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Gotham Asset Management's SGMO Position: Q4 2017 in Review

Gotham Asset Management sold out of SANGAMO THERAPEUTICS INC (SGMO) in Q4 2017, closing a stake of 26,695 shares — an estimated $400K sold.

Gotham Asset Management first reported a position in SGMO in Q4 2014 and held it in 3 quarters. The position peaked at $400K in Q3 2017. 170 funds tracked by Wall St. Rank hold SGMO as of Q4 2017.

  • Gotham Asset Management reported no remaining SANGAMO THERAPEUTICS INC position as of Q4 2017 after selling out during the quarter.
  • Gotham Asset Management sold 26,695 SANGAMO THERAPEUTICS INC shares in Q4 2017, an estimated $400K.
  • Gotham Asset Management first reported a position in SANGAMO THERAPEUTICS INC in Q4 2014 and held it in 3 quarters.
  • Gotham Asset Management's SANGAMO THERAPEUTICS INC position peaked at $400K in Q3 2017.
  • 170 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q4 2017.

Based on Gotham Asset Management's 13F filing for Q4 2017, filed 14 Feb 2018.